ES8800164A1 - Un procedimiento para preparar derivados de imidazolidina - Google Patents

Un procedimiento para preparar derivados de imidazolidina

Info

Publication number
ES8800164A1
ES8800164A1 ES556353A ES556353A ES8800164A1 ES 8800164 A1 ES8800164 A1 ES 8800164A1 ES 556353 A ES556353 A ES 556353A ES 556353 A ES556353 A ES 556353A ES 8800164 A1 ES8800164 A1 ES 8800164A1
Authority
ES
Spain
Prior art keywords
pyrrolidone derivatives
branched
alkyl
hydrogen
straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES556353A
Other languages
English (en)
Other versions
ES556353A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ISF SpA
Original Assignee
ISF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ISF SpA filed Critical ISF SpA
Publication of ES556353A0 publication Critical patent/ES556353A0/es
Publication of ES8800164A1 publication Critical patent/ES8800164A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PROCEDIMIENTO DE SINTESIS DERIVADOS DE IMIDAZOLINA. COMPRENDE: A) HACER REACCIONAR LOS COMPUESTOS DE FORMULAS (II) Y (III), EN PRESENCIA DE UN DISOLVENTE APROTICO, ENTRE 0 Y 50GC, Y DURANE 2 A 48 HORAS, PARA OBTENER UN COMPUESTO DE FORMULA (I); Y B) OBTENER UNA SAL FARMACEUTICAMENTE ACEPTABLE POR ADICION DE ACIDO. SIENDO: R ELEVADO A 1, H FENILO Y OTROS; W, ENLACE, -NHCHR ELEVADO A 6 CO-; R ELEVADO A 6, H O ALQUILO DE C 1 A 5; R ELEVADO A 2, H ARILO Y OTROS, R ELEVADO A 3 O R ELEVADO A 4, INDEPENDIENTEMENTE, ALQUILO, FENILO Y OTROS; R ELEVADO A 5; H O -CHR ELEVADO A 8 CONR ELEVADO A 9 R ELEVADO A 10; R ELEVADO A 8, R ELEVADO A 9 Y R ELEVADO A 10, IGUALES O DIFERENTES, H O R ELEVADO A 6; R ELEVADO A 11 Y R ELEVADO A 12, H O ACILO; X E Y, COMO W. *FORMULA*
ES556353A 1985-06-21 1986-06-20 Un procedimiento para preparar derivados de imidazolidina Expired ES8800164A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21234/85A IT1190378B (it) 1985-06-21 1985-06-21 Derivati pirrolidonici

Publications (2)

Publication Number Publication Date
ES556353A0 ES556353A0 (es) 1987-11-01
ES8800164A1 true ES8800164A1 (es) 1987-11-01

Family

ID=11178795

Family Applications (2)

Application Number Title Priority Date Filing Date
ES556353A Expired ES8800164A1 (es) 1985-06-21 1986-06-20 Un procedimiento para preparar derivados de imidazolidina
ES556351A Expired ES8801201A1 (es) 1985-06-21 1986-06-20 Un procedimiento para preparar derivados de pirrolidona

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES556351A Expired ES8801201A1 (es) 1985-06-21 1986-06-20 Un procedimiento para preparar derivados de pirrolidona

Country Status (20)

Country Link
US (1) US4824861A (es)
EP (1) EP0207681B1 (es)
JP (1) JPS62461A (es)
KR (1) KR930006766B1 (es)
AT (1) ATE73821T1 (es)
AU (1) AU587258B2 (es)
CA (1) CA1284248C (es)
DE (1) DE3684368D1 (es)
DK (1) DK290286A (es)
ES (2) ES8800164A1 (es)
FI (1) FI82446C (es)
GR (1) GR861577B (es)
HU (1) HU196225B (es)
IL (1) IL79136A (es)
IT (1) IT1190378B (es)
NO (1) NO168428C (es)
NZ (1) NZ216550A (es)
PH (1) PH22851A (es)
PT (2) PT82815B (es)
ZA (1) ZA864444B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209644B (it) * 1985-06-21 1989-08-30 Isf Spa Composti farmacologicamente attivi.
DK356288A (da) * 1987-07-30 1989-01-31 Lonza Ag Fremgangsmaade til fremstilling af n-((4-hydroxy-pyrrolidin-2-on-1-yl)-acetyl)-glycinamid
CA2007732A1 (en) * 1989-01-17 1990-07-17 Gary L. Olson Cyclohexaneacetamide derivatives
CH680293A5 (es) * 1990-06-26 1992-07-31 Lonza Ag
US6229011B1 (en) * 1997-08-22 2001-05-08 Hoffman-La Roche Inc. N-aroylphenylalanine derivative VCAM-1 inhibitors
NZ513254A (en) 1999-02-18 2003-10-31 F Thioamide derivatives
ATE264835T1 (de) 1999-02-18 2004-05-15 Hoffmann La Roche Phenylalaninolderivate
WO2009145839A1 (en) * 2008-04-04 2009-12-03 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Polyamine compounds that bind tar rna of hiv and methods of treating viral disorders
CN101914052B (zh) * 2010-08-02 2012-06-27 胡建荣 一种奥拉西坦化合物的制备方法
CN102351770B (zh) * 2011-08-12 2012-07-04 江西新先锋医药有限公司 一种奥拉西坦化合物及其药物组合物
CN112724062B (zh) * 2021-01-19 2022-03-15 江苏诚信药业有限公司 一种奥拉西坦杂质b的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH470396A (de) * 1963-08-12 1969-03-31 Hoffmann La Roche Verfahren zur Herstellung von 4-Imidazolidon-Verbindungen
IT1045043B (it) * 1975-08-13 1980-04-21 Isf Spa Derivati pirrolidinici
YU39660B (en) * 1976-01-14 1985-03-20 Pliva Pharm & Chem Works Process for obtaining 2-oxo-1-pyrrolidine acetamide
AT360980B (de) * 1976-01-14 1981-02-10 Pliva Pharm & Chem Works Verfahren zur herstellung von n-alkylamiden des 2-oxo-1-pyrrolidins
GB1539817A (en) * 1976-10-22 1979-02-07 Ucb Sa N-substituted lactams
IT1075564B (it) * 1977-02-11 1985-04-22 Isf Spa Procedimento per la preparazione di derivati pirrolidinici
IT1141287B (it) * 1979-06-13 1986-10-01 Nattermann A & Cie Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
FR2515179A1 (fr) * 1981-07-24 1983-04-29 Hoffmann La Roche Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
FI840261A (fi) * 1983-01-27 1984-07-28 Ciba Geigy Ag Substituerade pyrrolidinonderivat och foerfarande foer deras framstaellning.
IT1209644B (it) * 1985-06-21 1989-08-30 Isf Spa Composti farmacologicamente attivi.
JPH0681502B2 (ja) * 1988-07-14 1994-10-12 富士通電装株式会社 並列運転保護回路

Also Published As

Publication number Publication date
JPS62461A (ja) 1987-01-06
ES556353A0 (es) 1987-11-01
US4824861A (en) 1989-04-25
NO168428B (no) 1991-11-11
EP0207681A2 (en) 1987-01-07
IT1190378B (it) 1988-02-16
ES8801201A1 (es) 1988-01-01
PT82813A (en) 1986-07-01
EP0207681B1 (en) 1992-03-18
NO862486D0 (no) 1986-06-20
NO862486L (no) 1986-12-22
HU196225B (en) 1988-10-28
ES556351A0 (es) 1988-01-01
KR870000294A (ko) 1987-02-17
NZ216550A (en) 1990-02-26
GR861577B (en) 1986-10-21
KR930006766B1 (ko) 1993-07-23
PT82815A (en) 1986-07-01
CA1284248C (en) 1991-05-14
ATE73821T1 (de) 1992-04-15
FI82446B (fi) 1990-11-30
IT8521234A0 (it) 1985-06-21
DK290286D0 (da) 1986-06-20
FI82446C (fi) 1991-03-11
PH22851A (en) 1989-01-19
AU587258B2 (en) 1989-08-10
FI862420A (fi) 1986-12-22
HUT43815A (en) 1987-12-28
IL79136A (en) 1991-07-18
FI862420A0 (fi) 1986-06-06
PT82813B (pt) 1988-04-21
ZA864444B (en) 1987-02-25
DK290286A (da) 1986-12-22
DE3684368D1 (de) 1992-04-23
PT82815B (pt) 1988-04-21
NO168428C (no) 1992-02-19
EP0207681A3 (en) 1988-06-01
IL79136A0 (en) 1986-09-30
AU5891986A (en) 1986-12-24

Similar Documents

Publication Publication Date Title
JO1502B1 (en) New pharmacy vehicles
EP0564739A3 (es)
IE882929L (en) "immunomodulatory azaspiranes"
ES8604128A1 (es) Un procedimiento para la preparacion de nuevos derivados de bencenosulfonamida
EP0268377A3 (en) Glutamic acid derivatives, processes and intermediates for their preparation and pharmaceutical formulations containing them
ES8800164A1 (es) Un procedimiento para preparar derivados de imidazolidina
ES8700233A1 (es) Un procedimiento para preparar 1,3,4,5-tetrahidro-benz(cd) indolaminas oxigenadas en posicion 6
ES2001775A6 (es) Un procedimiento para preparar derivados de 2-cianofenetilamina
ES8601915A1 (es) Un procedimiento para preparar derivados de piridazinona
ES8700242A1 (es) Un procedimiento para preparar un derivado de dihidropirida-zinona
ES8609286A1 (es) Un metodo para preparar un compuesto de morfolinol
ES8802222A1 (es) Un procedimiento para preparar derivados de vinilisoquinolina
DE3666223D1 (en) Anticonvulsant agents
GR3000904T3 (en) Amide derivatives
GR850484B (es)

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506